Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Mao

Showing results (581-590 of 618) with videos related to

Pageof 62
Sort By:
World Journal of Gastroenterology|November 8, 2003
Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trialLun-Gen Lu, Min-De Zeng, Yi-Min Mao, et al.
The European Respiratory Journal|December 23, 2018
Germline <i>BMP9</i> mutation causes idiopathic pulmonary arterial hypertensionXiao-Jian Wang, Tian-Yu Lian, Xin Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2019
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II StudyWen-Zhao Zhong, Ke-Neng Chen, Chun Chen, et al.
Theranostics|January 6, 2022
Comprehensive omics analyses profile genesets related with tumor heterogeneity of multifocal glioblastomas and reveal LIF/CCL2 as biomarkers for mesenchymal subtypeSheng-Qing Lv, Zhen Fu, Lin Yang, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2022
Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trialJia-Bo Wang, Ang Huang, Yijin Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 23, 2020
[Application of CpG Oligodeoxynucleotide Immunostimulation in Chromosome Study of Chronic Lymphoblastic Leukemia]Ai Er Ken Mai DI Na, Hong Liu, Yi-Lin Wang, et al.
Cancer Cell|September 26, 2025
Ketogenic diet inhibits glioma progression by promoting gut microbiota-derived butyrate productionMing-Liang Chen, Ying He, Xun-Hu Dong, et al.
The Journal of Pathology|April 15, 2026
Human induced pluripotent stem cell-derived chimeric antigen receptor-macrophages eradicate IL-13Rα2-positive solid tumorsYing Yang, Lujing Wang, Yi Zhang, et al.
The European Respiratory Journal|January 22, 2026
sST2 and IL-6 predict prognosis of medically treated chronic thromboembolic pulmonary hypertensionChao Liu, Bao-Chen Qiu, Shuang-Ping Li, et al.
Signal Transduction and Targeted Therapy|February 23, 2023
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trialWen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen, et al.
Pageof 62

Showing results (581-590 of 618) with videos related to

Sort By:
Pageof 62
World Journal of Gastroenterology|November 8, 2003
Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trialLun-Gen Lu, Min-De Zeng, Yi-Min Mao, et al.
The European Respiratory Journal|December 23, 2018
Germline <i>BMP9</i> mutation causes idiopathic pulmonary arterial hypertensionXiao-Jian Wang, Tian-Yu Lian, Xin Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2019
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II StudyWen-Zhao Zhong, Ke-Neng Chen, Chun Chen, et al.
Theranostics|January 6, 2022
Comprehensive omics analyses profile genesets related with tumor heterogeneity of multifocal glioblastomas and reveal LIF/CCL2 as biomarkers for mesenchymal subtypeSheng-Qing Lv, Zhen Fu, Lin Yang, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2022
Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trialJia-Bo Wang, Ang Huang, Yijin Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 23, 2020
[Application of CpG Oligodeoxynucleotide Immunostimulation in Chromosome Study of Chronic Lymphoblastic Leukemia]Ai Er Ken Mai DI Na, Hong Liu, Yi-Lin Wang, et al.
Cancer Cell|September 26, 2025
Ketogenic diet inhibits glioma progression by promoting gut microbiota-derived butyrate productionMing-Liang Chen, Ying He, Xun-Hu Dong, et al.
The Journal of Pathology|April 15, 2026
Human induced pluripotent stem cell-derived chimeric antigen receptor-macrophages eradicate IL-13Rα2-positive solid tumorsYing Yang, Lujing Wang, Yi Zhang, et al.
The European Respiratory Journal|January 22, 2026
sST2 and IL-6 predict prognosis of medically treated chronic thromboembolic pulmonary hypertensionChao Liu, Bao-Chen Qiu, Shuang-Ping Li, et al.
Signal Transduction and Targeted Therapy|February 23, 2023
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trialWen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen, et al.
Pageof 62